Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Submitted by
admin
on November 13, 2014 - 11:29am
Source:
Reuters
News Tags:
Humira
Amgen
biosimilars
Headline:
Humira is in the crosshairs as Amgen gets its first Phase III biosimilars win
Do Not Allow Advertisers to Use My Personal information
